Given the role of p38 signaling in breast cancer promotion and progression, we further investigated the therapeutic potential of targeting this pathway by determining whether p38 pharmacological inhibition could reverse the neoplastic changes found in these cells. Here, MAPK14 is linked to breast cancer.